Gyre Therapeutics GYRE
NASDAQ GYRE
$4.26 +0.03 (+0.71%)
At close: Nov 11, 2026 · 4:00 PM EST

Gyre Therapeutics (GYRE) Depreciation and Depletion (2025 - 2026)

Updated

Gyre Therapeutics (GYRE) reported Depreciation and Depletion of $1.1 million for Q2 2026, up 37.5% from $800,000 a year earlier.

Analysis

Gyre Therapeutics (GYRE) Depreciation and Depletion (2025 - 2026) Analysis & Trends

For FY2025, Gyre Therapeutics posted Depreciation and Depletion of $2 million, up 53.8% from FY2024.

  • Depreciation and Depletion has increased for three consecutive years, with a three-year compound annual growth rate of 30.5% (FY2022 to FY2025).
  • By year, Depreciation and Depletion came in at $1.3 million in FY2024 (+30.0%), $1 million in FY2023 (+11.1%) and $900,000 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 192.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 132.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Gyre Therapeutics 487.81 Mn 295.13 Mn 30.99 Mn 300,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 300,000.00
Jun 30, 2026 1.10 Mn
Sep 30, 2025 700,000.00
Jun 30, 2025 800,000.00
API Access

Gyre Therapeutics Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=GYRE&period=max&api_key=YOUR_API_KEY